52 results
S-8
EX-5.1
SLN
Silence Therapeutics Plc
1 Aug 23
Registration of securities for employees
4:31pm
the Silence Therapeutics plc 2018 Employee Long Term Incentive Plan with U.S. Sub-Plan (the “2018 Employee LTIP”) and the Silence Therapeutics plc 2018 Non … -Employee Long Term Incentive Plan with U.S. Non-Employee Sub-Plan (the “2018 Non-Employee LTIP” and, together with the 2018 Employee LTIP, the “2018
S-8
EX-99.1
SLN
Silence Therapeutics Plc
1 Aug 23
Registration of securities for employees
4:31pm
, as amended from time to time.
(jj) “Prior Plans” means the (i) 2018 Employee Long Term Incentive Plan with US Sub-Plan and CSOP schedule for UK … employees; and (ii) 2018 Non-Employee Long Term Incentive Plan with US Sub-Plan.
(kk) “Quarter Date” means each of 1 January, 1 April, 1 July, and 1
S-8
EX-99.2
smveosdvw 2t395ys
1 Aug 23
Registration of securities for employees
4:31pm
S-8
5r6h v5pkze8b
1 Aug 23
Registration of securities for employees
4:31pm
S-8
6dicgowqsev37ov mpo
1 Aug 23
Registration of securities for employees
4:31pm
S-8
EX-99.3
m0966383kxm1uj4wqhc
1 Aug 23
Registration of securities for employees
4:31pm
6-K
EX-99.1
qdxcxtmxz20biehgib
4 May 23
Silence Therapeutics Achieves $10 Million Milestone Payment from AstraZeneca Collaboration
7:41am
6-K
EX-1.1
spo3b
16 Aug 22
Current report (foreign)
4:43pm
424B5
e5728jsl7lrt
12 Aug 22
Prospectus supplement for primary offering
1:32pm
6-K
EX-99.1
nf15vkai 8kac
22 Feb 22
Silence Therapeutics Appoints Craig Tooman President and Chief Executive Officer
6:52am
6-K
EX-99.1
b3t75
16 Nov 21
Current report (foreign)
6:03am
424B5
00sra15jiu3bm36ads
22 Oct 21
Prospectus supplement for primary offering
4:34pm
POS AM
x40hh
18 Oct 21
Prospectus update (post-effective amendment)
5:29pm
F-3
6og00k8j
15 Oct 21
Shelf registration (foreign)
7:41am
F-3
EX-1.1
4p6ni48m654gadby n7h
15 Oct 21
Shelf registration (foreign)
7:41am